NeuralCure AI

We recently published a list of Top 8 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at where Nano-X Imaging Ltd. (NASDAQ:NNOX) stands against other top AI news updates investors should not miss.

India's healthtech startups attracted approximately USD 233.5 million in funding, in the first half of 2024. Yet, behind the numbers lies a pressing question echoing across clinics, policy tables, and investor meetings: Is artificial intelligence (AI) the panacea India's overburdened healthcare system needs,

The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development. Traditional methods often take over a decade and billions of dollars to bring a single drug to market,

Medical errors are the third leading cause of death in the U.S., contributing to over 250,000 preventable deaths each year. NeuralCure AI is tackling this crisis head-on by eliminating diagnostic blind spots and accelerating treatment precision with its cutting-edge AI-driven decision support system.

The new Microsoft Dragon Copilot solution leverages generative AI-powered ambient listening voice recognition to automate clinical documentation, enhance administrative efficiency and allow clinicians to focus on patient care. Kyndryl will begin offering Dragon Copilot in its healthcare services portfolio beginning in May 2025.

UNC Charlotte researchers are contributing to pioneering breakthroughs in cancer therapeutics, communicable disease forecasting and prevention, optical applications for health care, and use of AI and other innovative computational tools — and more.

SimCare AI, founded by two University of Chicago dropouts, has secured $2 million in seed funding to expand its AI-driven healthcare simulation platform. The company's solution uses realistic AI patients to set a new clinical benchmark, cutting training time and cost while meeting strict accreditation standards.

AI models can pass complicated medical exams, read MRI scans and blood tests, and provide diagnoses. But medical bodies and AI developers urge patients to remain cautious.